Interestingly, regardless of MAFLD status, low maternal plasma adiponectin and high selenoprotein P levels were independent predictors of GDM development, suggesting that both biomarkers may be useful in predicting GDM and MAFLD [12]. The gene discussed is SELENOP; the disease is gestational diabetes.